Indications and uses
relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours
relieves occasional constipation (irregularity) generally causes bowel movement in 6 to 12 hours
• shake well before using • Do not exceed recommended dose Age Starting Dose Maximum Dose adults and children 12 years and older 2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor 3 teaspoons in the morning and 3 teaspoons at bedtime Under 12 years of age ask a doctor ask a doctor
Sennosides 8.8 mg Laxative
Do not use
• laxative products for longer than 1 week unless directed by a doctor.
• stomach pain • nausea • vomiting
• noticed a change in bowel movement that continues over a period of 2 weeks
you have rectal bleeding or failure to have a bowel movement after use of laxative. These may indicate a serious condition.
ask a health professional before use.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
• shake well before using • Do not exceed recommended dose
| Age | Starting Dose | Maximum Dose |
| adults and children 12 years and older | 2 to 3 teaspoonfuls once a day preferably at bedtime; increase as needed or as recommended by a doctor | 3 teaspoons in the morning and 3 teaspoons at bedtime |
| Under 12 years of age | ask a doctor | ask a doctor |
NDC 0904-7528-41: 5 mL unit dose cup, in a tray of ten cups.
NDC 0904-7528-94: Case contains 40 unit dose cups of 5 mL (0904-7528-41) packaged in 4 trays of 10 unit dose cups each.
citric acid, glycerin, methylparaben, potassium sorbate, propylparaben, purified water, and sucrose.
Call 1-800-845-8210.
R10/24
MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 4 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0904-7528-41 | Senna | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 4 | |
| 0904-7528-94 | Senna | 10 in 1 TRAY | LIQUID | 10 | 4 | |
| 0904-7528-94 | Senna | 4 in 1 CASE | LIQUID | 4 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-7528-41 | ML - Milliliter | 0904-7528 | 0dca331c-3b4f-4b5c-a790-de8da6815417 | 1 | 2025-05-14 |
| 0904-7528-94 | ML - Milliliter | 0904-7528 | cbef6a9d-7673-48a6-bf20-a9ab7ec37808 | 1 | 2025-05-14 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0904-7528 | 0904-7528-41, 0904-7528-94 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CITRIC ACID | 2968PHW8QP | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SUCROSE | C151H8M554 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna | SENNOSIDES | Major Pharmaceuticals | cfb6bf89-c77e-4372-9bc9-44d6a659c955 | 2025-07-18 | Warnings | 0904-7528-94 0904-7528-41 0904-7528 00904752894 00904752841 77e88305-734a-4b15-bbfe-67a32f02c143 cfb6bf89-c77e-4372-9bc9-44d6a659c955 |
Adverse event summaries are temporarily unavailable. Other product information remains available.